Are A.I. Models Being Misled to Act Too Human?
A corporate spat between two tech giants last week was just the latest volley in a conflict over whether dangerous mistakes are being made in A.I. training.
Read moreELISpot and FluoroSpot Assay Market to show extraordinary CAGR of 16.2 % | Revealing Key Drivers, Trends and Top Key Players by 2022
May 9, 2019
Global ELISpot and FluoroSpot Assay Market Report Split Into Several Key Regions, With Sales, Revenue, And Market Share And Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa....
Pune, India - May 9, 2019 /MarketersMedia/ —
The ELISpot and FluoroSpot Assay are using to detect various antibodies, cytokines, and granzymes. These kits are applicable for early diagnose diseases such as TB and tick-borne diseases. In these techniques’ cells are cultured on plates that are coated with antibodies which capture specific target molecules. The distribution of these analytes is then spotted through a sandwich ELISA where the analyte is capture. The global ELISpot and FluoroSpot assay market were estimated USD 135 million in 2017 and expected to reach USD 287 million by 2023 at a CAGR of 16.2% during the forecast period.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6948
The factor contributing for the market growth of ELISpot and FluoroSpot assay kits are increasing development for new vaccines for various treatments and innovation in pharma & biotech industry for the development of vaccines, rising clinical trials and growing healthcare expenditure by the population. However, factors such as high cost of ELISpot and FluoroSpot assay, lack of skilled technicians and alternative techniques are expected to hinder the growth of ELISpot and FluoroSpot assay market during the forecast period.
Key players:
• Oxford Immunotec (UK),
• Cellular Technologies (US),
• Mabtech (Sweden),
• Becton, Dickinson and Company (US),
• Abcam (UK)
• Bio-Techne (US),
• Autoimmun Diagnostika (Germany),
• Biotech Investissement (France),
• Lophius Biosciences (Germany),
• U-CyTech (Netherlands).
Segmentation:
The Global ELISpot and FluoroSpot Assay Market is segmented on the basis of product, application, and end-user. The ELISpot and FluoroSpot Assay market, by product is categorised into various assay kit, analyzer, ancillary products. The assay kit is sub-segmented into T Cell assay and B Cell assay. On the basis of application, the market is segmented into transplant, vaccines development, clinical trials, cancer treatment. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centres, diagnostic centres, research centers, and others.
Regional Analysis:
Europe stood second largest in the ELISpot and FluoroSpot Assay market owing to the increasing number of pharmaceutical companies, rising in the development of innovative vaccines for the treatment of various viral diseases. The growing funding from government and private agencies for drug development also support the ELISpot and FluoroSpot Assay market in this region. Asia-Pacific was estimated to be the fastest growing region for the global ELISpot and FluoroSpot Assay market in 2017. The market is expected to witness growth owing to the rising prevalence of viral infection, increasing geriatric population in this region and growing demand for ELISpot and FluoroSpot Assay in research field.
The Middle East and Africa holds the least share in the global ELISpot and FluoroSpot Assay market due to the presence of low health expenditure, lack of skilled technicians and less pharmaceutical company in this region. However, the market is expected to witness growth due to increasing research & development in the Middle East.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/elispot-and-fluorospot-assay-market-6948
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/elispot-and-fluorospot-assay-market-6948
Source: MarketersMedia
Release ID: 510565
More News
Google Fined €403 Million Over GDPR Violations Tied to Location Data
Google has been fined €403 million for breaking the EU's data protection law, the GDPR, in the way three of its features handled people's location data from May 2018 to February 2020. Ireland's Data Protection Commission (DPC), Google's lead regulator in the EU, also ordered the company to make its processing comply with the law within 6 months. The DPC has not said publicly which
Read more
How Potential 2028 Presidential Candidates Are Talking About A.I.
Democrats are jockeying to embrace new safeguards, while Republicans have aligned with President Trump’s warnings against slowing down the technology.
Read more
Human-Caused Warming Played ‘Very Strong’ Role in Himalayan Floods, Report Finds
Rising temperatures contributed to the disaster by destabilizing the permafrost and ice around the collapsed rock, scientists concluded.
Read more
Earth is on track for the hottest year on record, experts say - amid warnings Super El Niño could send temperatures soaring even higher in 2027
Earth is on track for its hottest year on record after a brutal summer of extreme temperatures, experts say.
Read more
The A.I. Party House Where Networking Has a Dark Side
Group tech houses have proliferated across the San Francisco Bay Area in the artificial intelligence boom. One of the most prominent has also racked up an extensive police record.
Read more
⚡ Weekly Recap: Cisco 0-Day, AI Agent RCE, ClickFix Attacks, ClickFix Surge, and Browser Hijacks
A browser. A plugin. A package. A login screen. Normal stuff. That is basically the problem this week. The trouble keeps showing up inside things people already trust: code that takes a bad turn, old payloads coming back, exposed systems, weak checks, fake fixes, and attack paths that look almost too easy. Even the research side is getting messy, with more findings, more automation, and not
Read more
TASK#STOMP PowerShell Backdoor Steals Documents, Wi-Fi Passwords, and Clipboard Data
Cybersecurity researchers have disclosed details of a new campaign dubbed TASK#STOMP that delivers a PowerShell backdoor designed to harvest sensitive data from compromised hosts. The backdoor "automatically harvests and exfiltrates business documents, watches the filesystem for new files in real time, steals Wi-Fi passwords and clipboard contents, takes screenshots, and accepts arbitrary
Read more
Typhoon Dujuan tracking close to Tokyo triggers rare evacuation alert
More than 1.9 million people are under evacuation orders as Typhoon Dujuan batters Japan.
Read more
The science behind the catsuit: Experts reveal how Keely Hodgkinson's all-black speed suit helped propel her to victory
When middle-distance runner Keely Hodgkinson stormed to victory in London last week, the crowd were as wowed by her outfit as her performance.
Read more
As AI safety fears mount, can a US-China hotline prevent a global crisis?
The United States and China’s agreement to establish an official AI dialogue, including a proposed threat-notification system, marks a pragmatic step towards crisis prevention in their tech war, even as deep-seated divisions over chip access, model distillation and market dominance threaten to limit its impact, analysts said. Announced following high-level talks in New York on Sunday between US Treasury Secretary Scott Bessent, US Trade Representative Jamieson Greer and Vice-Premier He Lifeng,...
Read more
‘CMF becomes Indian’: Carl Pei announces Nothing’s India spin-off with local R&D and global ambitions
Nothing CEO Carl Pei has announced that CMF will spin out into a standalone, majority Indian-owned company with its headquarters and R&D operations in India. Nothing will retain a stake and provide engineering, software, supplier and global brand support as CMF expands its device portfolio.
Read moreRecommended
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.
Copyright © 2015 - 2026 The Star Journals. All Rights Reserved.